26 August 2020
Chief Science Officer of the SENS Research Foundation and VP of New Technology Discovery at AgeX Therapeutics, Inc. Author of Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime
We were fortunate to be invited to join in a recent interview with the author and biomedical gerontologist Aubrey de Grey. He has been interviewed in recent years in a number of news sources, including CBS 60 Minutes, the BBC, The New York Times, Fortune Magazine, The Washington Post, TED, Popular Science, The Colbert Report, Time, the Skeptics’ Guide to the Universe, and The Joe Rogan Experience.
As CEO GenFlow Biosciences Dr. Leire brings a solid biotechnology expertise through his experience in pharmaceutical industry (Pfizer, Schering Plough, Pharmacia), biotechnology (CEO of several private and public biotech companies such as APT Therapeutics, Paringenix…), academia (Research Associate at the Harvard AIDS Institute) and Private Equity (partner at Biofund Venture Capital). He is the inventor of several patents including a patent for a microbicide. He also serves on the board of several biotechnology companies (such as Immunethep, BSIM, …). Furthermore, Eric has been CEO of several gene and cell therapy companies such as Enochian Biosciences (Nasdaq: ENOB) or DanDrit Biotechnologies. He holds an MD from Grenoble University and an MBA from HEC, Paris and Kellogg, Northwestern University.